Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden

Cancer Causes and Control

Volumn 26, Issue 11, 2015, Pages 1627-1642

  Katz, Aaron J ^a   Chia, Victoria M ^a   Schoonen, Wilma M ^b   Kelsh, Michael A ^a  

^a AMGEN INC   (United States)

^b AMGEN LTD   (United Kingdom)

Author keywords

Acute lymphoblastic leukemia; Incidence; International; Potential years of life lost; Projections; Survival

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARGENTINA; ARTICLE; AUSTRALIA; AVERAGE POTENTIAL YEAR OF LIFE LOST; BRAZIL; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHINA; COLOMBIA; COSTA RICA; CZECH REPUBLIC; DENMARK; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; INFANT; ISRAEL; ITALY; JAPAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; NEW ZEALAND; ONSET AGE; POLAND; POPULATION DISTRIBUTION; PRIORITY JOURNAL; SINGAPORE; SOUTH KOREA; SPAIN; SURVIVAL RATE; SWEDEN; TUMOR VOLUME; UNITED KINGDOM; VERY ELDERLY; ASIA; COST OF ILLNESS; FACTUAL DATABASE; FEMALE; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NATIONAL HEALTH ORGANIZATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PUBLIC HEALTH; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIA; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NATIONAL CANCER INSTITUTE (U.S.); PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PUBLIC HEALTH; UNITED STATES; YOUNG ADULT;

EID: 84943365686     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0657-6     Document Type: Article

References (58)

1. Wartenberg D, Groves FD, Adelman AS (2008) Acute lymphoblastic leukemia: epidemiology and etiology. In: Estey EH, Faderl S, Kantarjian H (eds) Acute leukemias, 1st edn. Springer, Berlin, pp 77–93
2. Groves FD, Linet MS, Devesa SS (1995) Patterns of occurrence of the leukaemias. Eur J Cancer 31a:941–949
3. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ et al (2012) Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol 30:1663–1669. doi:10.1200/jco.2011.37.8018
4. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC et al (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730–2741. doi:10.1056/NEJMoa0900386
5. Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM et al (2005) Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 106:3760–3767. doi:10.1182/blood-2005-04-1623
6. Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E et al (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 27:911–918. doi:10.1200/jco.2008.18.6916
7. Sive JI, Buck G, Fielding A, Lazarus HM, Litzow MR, Luger S et al (2012) Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. Br J Haematol 157:463–471. doi:10.1111/j.1365-2141.2012.09095.x
8. Thomas DA, O’Brien S, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W et al (2010) Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. J Clin Oncol 28:3880–3889. doi:10.1200/jco.2009.26.9456
9. Oriol A, Vives S, Hernandez-Rivas JM, Tormo M, Heras I, Rivas C et al (2010) Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica 95:589–596. doi:10.3324/haematol.2009.014274
10. Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G et al (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood 109:944–950. doi:10.1182/blood-2006-05-018192
11. Gökbuget N, Stanze D, Beck J, Diedrich H, Horst HA, Huttmann A et al (2012) Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood 120:2032–2041. doi:10.1182/blood-2011-12-399287
12. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019–5032. doi:10.1182/blood-2011-01-293050
13. American Cancer Society (2011) Global cancer facts and figures, 2nd edn. American Cancer Society, Atlanta
14. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917. doi:10.1002/ijc.25516
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi:10.3322/caac.20107
16. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM (2012) Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood 119:34–43. doi:10.1182/blood-2011-04-347872
17. Dalmasso P, Pastore G, Zuccolo L, Maule MM, Pearce N, Merletti F et al (2005) Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967–2001. A report of the Childhood Cancer Registry of Piedmont. Haematologica 90:1197–1204
18. Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 112:416–432. doi:10.1002/cncr.23169
19. Parkin DM, Stiller CA, Draper GJ, Bieber CA (1988) The international incidence of childhood cancer. Int J Cancer 42:511–520
20. Yamamoto JF, Goodman MT (2008) Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 19:379–390. doi:10.1007/s10552-007-9097-2
21. Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164:536–545. doi:10.1111/bjh.12659
22. Marcos-Gragera R, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Maynadie M et al (2011) Survival of European patients diagnosed with lymphoid neoplasms in 2000–2002: results of the HAEMACARE project. Haematologica 96:720–728. doi:10.3324/haematol.2010.034264
23. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O et al (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734. doi:10.1182/blood-2010-05-282632
24. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D et al (2014) Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 15:23–34. doi:10.1016/s1470-2045(13)70546-1
25. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J et al (2014) Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol 15:35–47. doi:10.1016/s1470-2045(13)70548-5
26. Svendsen AL, Feychting M, Klaeboe L, Langmark F, Schuz J (2007) Time trends in the incidence of acute lymphoblastic leukemia among children 1976–2002: a population-based Nordic study. J Pediatr 151:548–550. doi:10.1016/j.jpeds.2007.07.006
27. Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E et al (2006) Leukaemia incidence and survival in children and adolescents in Europe during 1978–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2019–2036. doi:10.1016/j.ejca.2006.06.005
28. Fajardo-Gutierrez A, Juarez-Ocana S, Gonzalez-Miranda G, Palma-Padilla V, Carreon-Cruz R, Ortega-Alvarez MC et al (2007) Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the Cancer registry (a population-based study). BMC Cancer 7:68. doi:10.1186/1471-2407-7-68
29. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL (2005) A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl) 14:53–62. doi:10.1111/j.1365-2354.2005.00513.x
30. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kholer B, Piñeros M et al (2013) Cancer Incidence in Five Continents Volume X (IARC Scientific Publications No. 164). Lyon, IARC
31. Ahmad OB, Boschi-Pinto C, López AD, Murray CJLLR, Inoue M (2001) Age standardization of rates: a new WHO standard. World Health Organization, Geneva
32. United Nations, Department of Economic and Social Affairs, Population Division (2013) World Population Prospects: The 2012 Revision. http://esa.un.org/wpp/unpp/panel_indicators.htm. Accessed Feb 21, 2014
33. Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi P et al (2013) Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica 98:1702–1710. doi:10.3324/haematol.2012.080432
34. Toft N, Schmiegelow K, Klausen TW, Birgens H (2012) Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998–2008. Br J Haematol 157:97–104. doi:10.1111/j.1365-2141.2011.09020.x
35. Li X, Li J, Hu Y, Xie W, Du W, Liu W et al (2012) A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia. Leuk Res 36:720–726. doi:10.1016/j.leukres.2011.12.016
36. Chen B, Wang YY, Shen Y, Zhang WN, He HY, Zhu YM et al (2012) Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries. Leukemia 26:1608–1616. doi:10.1038/leu.2012.26
37. Dugas M, Messerer D, Hasford J, Haferlach T, Heinze B, Ludwig W et al (2003) German multicenter study group for adult ALL (GMALL): recruitment in comparison to ALL incidence and its impact on study results. Ann Hematol 82:83–87. doi:10.1007/s00277-002-0585-x
38. Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M et al (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109:3189–3197. doi:10.1182/blood-2006-10-051912
39. Tavernier E, Boiron JM, Huguet F, Bradstock K, Vey N, Kovacsovics T et al (2007) Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia 21:1907–1914. doi:10.1038/sj.leu.2404824
40. Kantarjian H, Thomas D, O’Brien S, Cortes J, Giles F, Jeha S et al (2004) Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 101:2788–2801. doi:10.1002/cncr.20668
41. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 18 Regs Research Data + Hurrican Katrina Impacted louisiana Cases, Nov 2013 Sub (1973–2011 varying)—Linked to County Attributes—Total U.S., 1969–2012 Counties, National Cancer Instisute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated 5/7/2017), based on the November 2013 submission
42. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality—All COD, Aggregated With State, Total U.S. (1969–2010) , National Cancer Instisute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013. Underlying mortality data provided by NCHS (www.cdc.gov/nchs)
43. World Health Organization (2013) Global Health Observatory Data Repository. http://apps.who.int/ghodata/. Accessed May 19, 2014
44. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP (2005) Years of life lost (YLL) from cancer is an important measure of population burden—and should be considered when allocating research funds. Br J Cancer 92:241–245. doi:10.1038/sj.bjc.6602321
45. Office for National Statistics (2015) Causes of Death. http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Causes+of+Death#tab-data-tables. Accessed Jan 8, 2015
46. NHS National Services Scotland, Information Services Division (2015) Data tables: cancer mortality by year. http://www.isdscotland.org/Health-Topics/Cancer/Publications/data-tables.asp?id=1314#1314. Accessed Jan 8, 2015
47. Instituto Nacional de Estadística (2015) Health: Deaths statistic according to cause of death. http://www.ine.es/jaxi/menu.do?type=pcaxis&path=%2Ft15%2Fp417&file=inebase&L=1. Accessed Jan 8, 2015
48. Australian Institute of Health and Welfare (AIHW) (2014) Australian Cancer Incidence and Mortality (ACIM) books: acute lymphoblastic leukemia. AIHW, Canberra. http://www.aihw.gov.au/acim-books. Accessed Jan 8, 2015
49. Ehngholm G, Ferlay J, Christensen N, Kejs AMT, Johannesen TB, Khan S, et al (2014) NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries, version 7.0. Association of the Nordic Cancer Registries. Danish Cancer Society. http://www.ancr.nu. Accessed Jan 8, 2015
50. Linet MS, Dores GM, Kim CJ, Devesa SS, Morton LM (2013) Epidemiology and hereditary aspects of acute leukemia. In: Wiernik PH, Goldman JM, Dutcher J (eds) Neoplastic diseases of the blood, 5th edn. Springer, New York, pp 199–212
51. Perez-Saldivar ML, Fajardo-Gutierrez A, Bernaldez-Rios R, Martinez-Avalos A, Medina-Sanson A, Espinosa-Hernandez L et al (2011) Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer 11:355. doi:10.1186/1471-2407-11-355
52. Novak I, Jaksic O, Kulis T, Batinjan K, Znaor A (2012) Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988–2009. Croat Med J 53:115–123
53. Hjalgrim LL, Rostgaard K, Schmiegelow K, Soderhall S, Kolmannskog S, Vettenranta K et al (2003) Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries. J Natl Cancer Inst 95:1539–1544
54. Rowe JM (2010) Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol 150:389–405. doi:10.1111/j.1365-2141.2010.08246.x
55. Faderl S, O’Brien S, Pui CH, Stock W, Wetzler M, Hoelzer D et al (2010) Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 116:1165–1176. doi:10.1002/cncr.24862
56. Ludwig H, Bolejack V, Crowley J, Blade J, Miguel JS, Kyle RA et al (2010) Survival and years of life lost in different age cohorts of patients with multiple myeloma. J Clin Oncol 28:1599–1605. doi:10.1200/jco.2009.25.2114
57. Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B et al (2014) Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol 15:931–942. doi:10.1016/s1470-2045(14)70282-7
58. Horibe K, Saito AM, Takimoto T, Tsuchida M, Manabe A, Shima M et al (2013) Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006–2010): based on registry data from the Japanese Society of Pediatric Hematology. Int J Hematol 98:74–88. doi:10.1007/s12185-013-1364-2